Novartis to cut 680 jobs in product development, Reuters reports

Novartis is cutting up to 680 jobs in its development organization, which helps bring its drugs to market, the Swiss pharmaceuticals company said on Tuesday, according to Reuters. Around 440 jobs will go in Switzerland and up to 240 in the United States over the next two to three years, the company said. The job eliminations are separate from a restructuring program which could lead up to 8,000 of Novartis’s 78,000 global workforce being cut, it added.